Neri P - Search Results

1

Gavile CM, Barwick BG, Newman S, Neri P, Nooka AK, Lonial S, Lee KP, Boise LH. Gavile CM, et al. Among authors: neri p. Blood Adv. 2017 Nov 16;1(25):2307-2319. doi: 10.1182/bloodadvances.2017011601. eCollection 2017 Nov 28. Blood Adv. 2017. PMID: 29296880 Free PMC article.

2

Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.

Neri P, Ren L, Azab AK, Brentnall M, Gratton K, Klimowicz AC, Lin C, Duggan P, Tassone P, Mansoor A, Stewart DA, Boise LH, Ghobrial IM, Bahlis NJ. Neri P, et al. Blood. 2011 Jun 9;117(23):6202-13. doi: 10.1182/blood-2010-06-292243. Epub 2011 Apr 7. Blood. 2011. PMID: 21474670 Free PMC article.

3

Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

Neri P, Ren L, Gratton K, Stebner E, Johnson J, Klimowicz A, Duggan P, Tassone P, Mansoor A, Stewart DA, Lonial S, Boise LH, Bahlis NJ. Neri P, et al. Blood. 2011 Dec 8;118(24):6368-79. doi: 10.1182/blood-2011-06-363911. Epub 2011 Sep 13. Blood. 2011. PMID: 21917757 Free PMC article.

4

Panobinostat for the treatment of multiple myeloma.

Neri P, Bahlis NJ, Lonial S. Neri P, et al. Expert Opin Investig Drugs. 2012 May;21(5):733-47. doi: 10.1517/13543784.2012.668883. Epub 2012 Mar 12. Expert Opin Investig Drugs. 2012. PMID: 22404247 Review.

5

Pinning down myeloma with Pim2 inhibitors!

Neri P, Bahlis NJ. Neri P, et al. Blood. 2013 Aug 29;122(9):1534-6. doi: 10.1182/blood-2013-07-514091. Blood. 2013. PMID: 23990611 Free article. No abstract available.

6

New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.

Neri P, Bahlis NJ, Lonial S. Neri P, et al. Clin Cancer Res. 2016 Dec 15;22(24):5959-5965. doi: 10.1158/1078-0432.CCR-16-0184. Epub 2016 Oct 19. Clin Cancer Res. 2016. PMID: 27797968 Review.

7

Multiple myeloma cells sent "PAKing"!

Neri P, Bahlis NJ. Neri P, et al. Blood. 2017 Apr 20;129(16):2208-2209. doi: 10.1182/blood-2017-02-764662. Blood. 2017. PMID: 28428234 Free article. No abstract available.

8

14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors.

Gu Y, Xu K, Torre C, Samur M, Barwick BG, Rupji M, Arora J, Neri P, Kaufman J, Nooka A, Bernal-Mizrachi L, Vertino P, Sun SY, Chen J, Munshi N, Fu H, Kowalski J, Boise LH, Lonial S. Gu Y, et al. Among authors: neri p. Leukemia. 2018 Mar;32(3):744-751. doi: 10.1038/leu.2017.288. Epub 2017 Sep 19. Leukemia. 2018. PMID: 28924240

9

CRISPRing the CRL4^CRBN RING in multiple myeloma.

Neri P. Neri P. Blood. 2018 Sep 20;132(12):1219-1220. doi: 10.1182/blood-2018-08-867069. Blood. 2018. PMID: 30237253 Free article. No abstract available.

10

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Matulis SM, Gupta VA, Neri P, Bahlis NJ, Maciag P, Leverson JD, Heffner LT Jr, Lonial S, Nooka AK, Kaufman JL, Boise LH. Matulis SM, et al. Among authors: neri p. Leukemia. 2019 May;33(5):1291-1296. doi: 10.1038/s41375-018-0374-8. Epub 2019 Jan 24. Leukemia. 2019. PMID: 30679802 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page